Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer

J Thorac Oncol. 2018 Apr;13(4):e55-e56. doi: 10.1016/j.jtho.2017.11.113.

Authors

Adrien Costantini¹, Jacques Cadranel²

Affiliations

¹ Chest Department, Tenon Hospital and GRC-04 Theranoscan Assistance, Publique-Hôpitaux de Paris, Pierre-and-Marie-Curie University, Paris, France.
² Chest Department, Tenon Hospital and GRC-04 Theranoscan Assistance, Publique-Hôpitaux de Paris, Pierre-and-Marie-Curie University, Paris, France. Electronic address: jacques.cadranel@aphp.fr.

PMID: 29576291
DOI: 10.1016/j.jtho.2017.11.113

No abstract available

Publication types

Letter
Comment

MeSH terms

B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*
Programmed Cell Death 1 Receptor
Salvage Therapy

Substances

B7-H1 Antigen
Programmed Cell Death 1 Receptor